tiprankstipranks
iX Biopharma Adjusts Convertible Bonds Terms
Company Announcements

iX Biopharma Adjusts Convertible Bonds Terms

iX Biopharma Ltd. (SG:42C) has released an update.

Don't Miss Our Christmas Offers:

iX Biopharma Ltd. has announced adjustments to the conversion price of their S$2,000,000 convertible bonds, following their recent rights issue. The conversion price for converting bonds to new ordinary shares has been lowered from S$0.1337 to S$0.1200 per share, and the minimum conversion price has been adjusted from S$0.0819 to S$0.0700 per share. These changes are meant to reflect the rights cum warrants issue and are calculated based on a specific formula outlined in the Bond Subscription Agreement.

For further insights into SG:42C stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Singapore Auto-Generated NewsdeskiX Biopharma’s iXB 401: A Breakthrough in Drug Delivery
TipRanks Singapore Auto-Generated NewsdeskiX Biopharma Unveils Growth Plans at AGM
TipRanks Singapore Auto-Generated NewsdeskiX Biopharma Ltd. Holds Key Shareholder Meeting
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App